Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K070784
    Device Name
    INION BIORESTORE
    Manufacturer
    Date Cleared
    2007-07-24

    (125 days)

    Product Code
    Regulation Number
    872.3930
    Panel
    Dental
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K000149, K040278, K053022, K023998, K860983

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The INION BIORESTORE™ implants are bone graft substitutes indicated for bony voids or gaps that are not intrinsic to the stability of the bony structure; packing into bony voids or gaps to fill and/or augment dental intraosseous, oral and craniomaxillofacial defects. These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone, including: e.g., periodontal/infrabony defects; alveolar ridge augmentation (sinusotomy, osteotomy); dental extraction sites (ridge maintenance, implant preparation/placement); sinus lifts; cystic defects; and craniofacial augmentation.

    Device Description

    Inion BioRestore™ is an osteoconductive and osteostimulative bioactive bone graft substitute used either separately or in conjunction with autogenous or allograft bone. When implanted, a kinetic modification of the surface occurs, resulting in the formation of a calcium phosphate layer that is essentially similar in composition and structure to the hydroxyapatite found in bone mineral. This apatite layer provides scaffolding onto which the patient's new bone will grow allowing complete repair of the defect. Inion BioRestore™ system consists of different size cylinders, blocks and morsels made of degradable bioactive glass. Inion BioRestore™ implants degrade in vivo in six months based on pre-clinical data. The material is radiopaque. Inion BioRestore™ implants are intended for single use and are provided sterile to the user. They are completely synthetic and non-collagenous.

    AI/ML Overview

    This document is a 510(k) summary for Inion BioRestore™, a bone graft substitute, and does not contain information about acceptance criteria or a study that proves the device meets specific performance criteria.

    The 510(k) process is primarily focused on demonstrating substantial equivalence to a legally marketed predicate device, rather than detailed performance studies with acceptance criteria or comparative effectiveness studies.

    Therefore, I cannot provide the requested information based on the provided text. The document refers to "performance data and specifications presented" for demonstrating substantial equivalence, but it does not describe what those specific data points or acceptance criteria were. It also mentions "pre-clinical data" for degradation, but not details of the study.

    Here's a breakdown of why each point cannot be answered:

    1. A table of acceptance criteria and the reported device performance: Not present. The document focuses on showing equivalence to predicate devices, not on meeting predefined performance metrics.
    2. Sample sized used for the test set and the data provenance: Not present. No specific test set or study data is detailed.
    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable/present. No test set requiring expert ground truth is described.
    4. Adjudication method: Not applicable/present.
    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. This document describes a medical device (bone graft substitute), not an AI-assisted diagnostic tool.
    6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done: Not applicable.
    7. The type of ground truth used: Not applicable/present.
    8. The sample size for the training set: Not applicable/present.
    9. How the ground truth for the training set was established: Not applicable/present.
    Ask a Question

    Ask a specific question about this device

    K Number
    K063596
    Date Cleared
    2007-02-22

    (80 days)

    Product Code
    Regulation Number
    872.3930
    Panel
    Dental
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K040278, K992416, K962492, K930115, K000149

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The intended use of PerioGlas Putty is to provide a safe, biocompatible synthetic bone graft material for use in oral, dental intraosseous, and craniofacial defects. It is used alone in a manner comparable to autogenous bone graft chips or allograft bone particulate (Demineralized Freeze Dried Bone) or may be mixed with either (typically 1:1 ratio v/v) as a bone graft extender. Typical uses include:

    • Periodontal/Infrabony defects
    • Ridge Augmentation (sinusotomy, osteotomy, cystectomy)
    • Extraction sites maintenance/augmentation, implant (ridge preparation/ placement)
    • Sinus lifts
    • Cystic cavities
    • Cranio-facial augmentation

    For larger defects, a mixture of PerioGlas Putty with an equal volume of allograft or autograft bone and bone marrow may improve new bone formation.

    Device Description

    PerioGlas Putty is an osteoconductive, bioactive, bone void filler device. The device is intended for dental intraosseous, oral, and cranio-/maxillofacial bony defects and is supplied sterile. PerioGlas Putty is a two-component device composed of a synthetic bioactive glass particulate mixed with a binder. The a melt-derived calcium-phosphorus-sodium-silicate major component is designed specifically for for its absorbability (Bioglass) particulate and osteoconductive nature. The second component is gelatin powder, selected for its biocompatibility and physical gelation properties to act as a temporary binding agent for the particulate. The gelatin is rapidly absorbed from the graft site to permit tissue infiltration between the Bioglass particles and replacement of the particles by host bone during the healing process.

    AI/ML Overview

    I'm sorry, but the provided text does not contain the information needed to answer your request. The document describes a 510(k) premarket notification for a medical device (PerioGlas Putty - Bioactive Bone Graft Gel) and focuses on demonstrating substantial equivalence to predicate devices, rather than presenting a study with specific acceptance criteria and performance data.

    Therefore, I cannot provide:

    • A table of acceptance criteria and reported device performance.
    • Sample sizes used for test sets or data provenance.
    • Number and qualifications of experts for ground truth.
    • Adjudication method.
    • MRMC comparative effectiveness study details.
    • Standalone algorithm performance.
    • Type of ground truth used.
    • Sample size for the training set.
    • How ground truth for the training set was established.

    This document is primarily about regulatory clearance based on substantial equivalence, not a detailed performance study with the metrics you've requested.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1